GAD-alum given into lymph nodes to Type 1 diabetes patients participating in an open-label pilot trial resulted in preservation of C-peptide similar to promising results from other trials (Journal of Diabetes Research)
Diabetes News
Tag: GAD
New analyses by international diabetes expertise provides strong support for the Diamyd® diabetes vaccine
In an abstract submitted to a scientific meeting the authors conclude that the GAD-based diabetes vaccine Diamyd®, with very high probability preserves patients’ insulin producing capacity and that the continued development should aim to increase the efficacy (Diamyd)
Glycosmedia is also available as an App: